
11 - 50 employees
Founded 2018
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $402M Post-IPO Equity on 2025-12
Biotechnology • Pharmaceuticals
Belite Bio is a clinical-stage biopharmaceutical company developing novel therapeutics based on its RBP4 (Retinol Binding Protein 4) intellectual property portfolio. Its lead candidate, tinlarebant (LBS-008), is an oral therapy designed to reduce toxic accumulations in the eye and is being developed for retinal degenerative diseases including autosomal recessive Stargardt disease (STGD1) and Geographic Atrophy (advanced dry age-related macular degeneration). Belite Bio is conducting multiple clinical trials (Phase 1b/2, Phase 2/3, and Phase 3 programs such as DRAGON, DRAGON II, and PHOENIX) and tinlarebant has received several regulatory designations (Orphan Drug in US/EU/Japan, Rare Pediatric Disease, Breakthrough Therapy, Fast Track, and Sakigake). The company’s pipeline also includes programs addressing metabolic and liver diseases (e. g. , non-alcoholic fatty liver disease and type 2 diabetes).
📡 We watch Belite Bio's careers page
Several times a day
how often we check
15
roles posted in the last 30 days
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🔥 1 minute ago
Regional sales leader building and coaching a field team for Belite Bio, a retinal disease biopharmaceutical company. Driving pre-launch and launch strategy across the U.S. South.
🇺🇸 United States – Remote
💵 $250k - $285k / year
🔥 Funding within the last year
💰 $402M Post-IPO Equity on 2025-12
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 0%
🔥 1 minute ago
Regional sales leader building and coaching Territory Business Manager teams for Belite Bio’s retinal disease therapy launch. Driving commercial strategy, market access, and compliant field execution across the western USA.
🏄 California – Remote
💵 $250k - $285k / year
🔥 Funding within the last year
💰 $402M Post-IPO Equity on 2025-12
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 0%
🔥 1 minute ago
Regional sales director building and coaching Territory Business Managers for Belite Bio’s retinal disease therapy launch. Driving compliant commercial strategy across U.S. retina and rare-disease markets.
🇺🇸 United States – Remote
💵 $250k - $285k / year
🔥 Funding within the last year
💰 $402M Post-IPO Equity on 2025-12
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 0%
🔥 1 minute ago
Medical Science Liaison advancing Belite Bio’s retinal disease therapeutics. Educating ophthalmology stakeholders and supporting US launch, KOL engagement, and clinical programs.
🏄 California – Remote
💵 $165k - $240k / year
🔥 Funding within the last year
💰 $402M Post-IPO Equity on 2025-12
⏰ Full Time
🟢 Junior
🟡 Mid-level
👻 Ghost score 0%
🔥 1 minute ago
Medical Science Liaison supporting Belite Bio’s retinal disease drug programs and US launch activities. Building ophthalmology KOL relationships and delivering compliant scientific education across Florida.
🐊 Florida – Remote
💵 $165k - $240k / year
🔥 Funding within the last year
💰 $402M Post-IPO Equity on 2025-12
⏰ Full Time
🟢 Junior
🟡 Mid-level
👻 Ghost score 0%
🔥 1 minute ago
Medical Science Liaison supporting Belite Bio’s retinal disease drug development and launch activities. Building ophthalmology KOL relationships and delivering compliant scientific education across the US.
🇺🇸 United States – Remote
💵 $165k - $240k / year
🔥 Funding within the last year
💰 $402M Post-IPO Equity on 2025-12
⏰ Full Time
🟢 Junior
🟡 Mid-level
👻 Ghost score 0%
🔥 1 minute ago
Finance Director guiding budgeting, forecasting, and SEC reporting for Belite Bio, a clinical-stage biopharmaceutical company developing retinal disease therapeutics.
🇺🇸 United States – Remote
💵 $185k - $208k / year
🔥 Funding within the last year
💰 $402M Post-IPO Equity on 2025-12
⏰ Full Time
🔴 Lead
💸 Financial Planning and Analysis (FP&A)
👻 Ghost score 0%
🔥 1 minute ago
IT Director leading secure, compliant infrastructure and governance for Belite Bio’s retinal disease therapeutics. Managing policies, audits, quality systems, risks, and IT operations.
🏄 California – Remote
💵 $172k - $200k / year
🔥 Funding within the last year
💰 $402M Post-IPO Equity on 2025-12
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 0%
🔥 1 minute ago
Senior pharmacovigilance scientist supporting Belite Bio’s retinal disease drug development. Managing safety cases, signal detection, regulatory reporting, and global compliance.
🏄 California – Remote
💵 $148k - $160k / year
🔥 Funding within the last year
💰 $402M Post-IPO Equity on 2025-12
⏰ Full Time
🟠 Senior
🧪 Clinical Research
👻 Ghost score 0%
🔥 1 minute ago
Medical Director leading global safety and pharmacovigilance for Belite Bio’s retinal disease drug pipeline. Assessing clinical safety data, managing risk activities, and supporting regulatory submissions.
🏄 California – Remote
💵 $180k - $240k / year
🔥 Funding within the last year
💰 $402M Post-IPO Equity on 2025-12
⏰ Full Time
🔴 Lead
👨⚕️ Medical Director
👻 Ghost score 0%
🔥 1 minute ago
Regulatory CMC leader guiding Belite Bio’s small-molecule retinal disease therapeutics through global submissions, manufacturing changes, and post-approval commercialization.
🏄 California – Remote
💵 $180k - $195k / year
🔥 Funding within the last year
💰 $402M Post-IPO Equity on 2025-12
⏰ Full Time
🟠 Senior
🚔 Compliance
👻 Ghost score 0%
🔥 1 minute ago
Compliance operations director optimizing reporting, hotline, and risk systems for Belite Bio, a retinal disease drug development company. Leading pharmaceutical compliance infrastructure and continuous improvement.
🇺🇸 United States – Remote
💵 $223k - $240k / year
🔥 Funding within the last year
💰 $402M Post-IPO Equity on 2025-12
⏰ Full Time
🔴 Lead
🚔 Compliance
👻 Ghost score 0%
🔥 1 minute ago
Senior Manager optimizing LMS, policy, and third-party compliance operations for Belite Bio’s retinal disease therapeutics. Maintaining audit-ready training records and regulatory processes.
🏄 California – Remote
💵 $185k - $200k / year
🔥 Funding within the last year
💰 $402M Post-IPO Equity on 2025-12
⏰ Full Time
🟠 Senior
🚔 Compliance
👻 Ghost score 0%
🔥 1 minute ago
Patient marketing director advancing Belite Bio's retinal disease therapies. Leading omnichannel campaigns, media strategy, patient engagement, and launch initiatives for Stargardt disease and geographic atrophy.
🇺🇸 United States – Remote
💵 $200k - $240k / year
🔥 Funding within the last year
💰 $402M Post-IPO Equity on 2025-12
⏰ Full Time
🔴 Lead
🎡 Marketing
👻 Ghost score 0%
🔥 1 minute ago
HCP marketing director advancing retinal disease therapeutics at Belite Bio. Leading promotional strategy, peer engagement, agencies, budgets, and cross-functional launch execution.
🇺🇸 United States – Remote
💵 $210k - $250k / year
🔥 Funding within the last year
💰 $402M Post-IPO Equity on 2025-12
⏰ Full Time
🔴 Lead
🎡 Marketing
👻 Ghost score 0%